Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | KOD | Common Stock | Options Exercise | +5.49K | +10% | 60.4K | Jun 15, 2022 | Direct | F1 | ||
transaction | KOD | Common Stock | Sale | -$8.69K | -1.21K | -1.99% | $7.21 | 59.2K | Jun 15, 2022 | Direct | F2 |
transaction | KOD | Common Stock | Sale | -$16K | -2.28K | -3.85% | $7.02 | 56.9K | Jun 17, 2022 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | KOD | Restricted Stock Units | Options Exercise | $0 | -3.62K | -33.33% | $0.00 | 7.24K | Jun 15, 2022 | Common Stock | 3.62K | Direct | F1, F4 | |
transaction | KOD | Restricted Stock Units | Options Exercise | $0 | -1.88K | -25% | $0.00 | 5.63K | Jun 15, 2022 | Common Stock | 1.88K | Direct | F1, F5 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. |
F2 | The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 11, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). |
F3 | The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2022. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. The sale is intended to comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c). |
F4 | One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2020, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
F5 | One-fourth (1/4th) of the RSUs vest on each of the first four anniversaries of June 15, 2021, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Chief Medical Officer and Chief Development Officer